This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

China STEMI-PCI Program

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2012 by Yong Huo, Peking University First Hospital.
Recruitment status was:  Recruiting
Abbott Vascular
Information provided by (Responsible Party):
Yong Huo, Peking University First Hospital Identifier:
First received: October 26, 2012
Last updated: NA
Last verified: October 2012
History: No changes posted
  1. Registration
  2. Performing in three stages
  3. Major aim: Much more and standard reperfusion therapy in STEMI patients

ST Segment Elevation Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: China STEMI-PCI Program

Further study details as provided by Yong Huo, Peking University First Hospital:

Primary Outcome Measures:
  • The reperfusion ratio [ Time Frame: up to 1 day ]

Secondary Outcome Measures:
  • Door to Balloon time [ Time Frame: up to 1 day ]
  • BMS ratio [ Time Frame: up to 1 day ]
  • health economic evaluation [ Time Frame: up to 1 year ]

Estimated Enrollment: 4000
Study Start Date: December 2011
Estimated Study Completion Date: June 2016
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
STEMI Patients enrolled and followed up 1 year

Inclusion Criteria:

  • Onset of STEMI within 12h
  • Onset of STEMI within 12-36h needing primary PCI

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01716884

Contact: Yan Zhang, MD 8610-83575180

Division of Cardiology, Peking University First Hospital Recruiting
Beijing, China, 100034
Principal Investigator: Yong Huo, MD         
Sponsors and Collaborators
Peking University First Hospital
Abbott Vascular
  More Information

Responsible Party: Yong Huo, Director of cardiovascular department, Peking University First Hospital Identifier: NCT01716884     History of Changes
Other Study ID Numbers: 2011[436]
Study First Received: October 26, 2012
Last Updated: October 26, 2012

Keywords provided by Yong Huo, Peking University First Hospital:
primary PCI

Additional relevant MeSH terms:
Myocardial Infarction
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on August 18, 2017